What sex and gender differences exist in the incidence and clinical presentation of vitreous hemorrhage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sex and Gender Differences in Vitreous Hemorrhage

Men experience posterior vitreous detachment (PVD)—the most common cause of spontaneous vitreous hemorrhage—at an earlier age than women, and male gender is independently associated with higher risk of both vitreous hemorrhage incidence and subsequent retinal detachment complications.

Key Sex-Based Differences in Incidence and Timing

Age of Onset

  • PVD occurs earlier in men than women within the typical 45-65 year age range 11
  • This earlier PVD onset in males translates to earlier risk of associated vitreous hemorrhage

Overall Incidence

  • Male gender is a significant independent risk factor for vitreous hemorrhage (HR=1.07, p=0.03) 2
  • Males comprise approximately 60-70% of vitreous hemorrhage cases across multiple population studies 234
  • In a large Taiwanese population study, male predominance was consistent across all age groups 2

Clinical Presentation Differences

Risk of Retinal Detachment

The most clinically significant sex difference relates to complications:

  • Men have nearly 3-fold higher risk of rhegmatogenous retinal detachment (RRD) following vitreous hemorrhage from PVD (HR=2.90,95% CI 1.64-5.12, p<0.001) 5
  • This represents a critical morbidity difference, as RRD requires urgent surgical intervention to prevent permanent vision loss
  • The RRD risk peaks within the first 20 days after vitreous hemorrhage onset 5

Age-Gender Interaction

  • Younger male patients face the highest risk of complications 53
  • Male sex combined with age >8 years is significantly associated with severe visual loss in pediatric/adolescent populations 3
  • Older patients (>65 years) show lower RRD risk regardless of gender (HR=0.25-0.27) 5

Etiological Considerations

While the guidelines don't specify different underlying causes by sex, the epidemiological pattern suggests:

  • Trauma-related vitreous hemorrhage shows male predominance (approximately 65% male in blunt trauma cases) 3
  • Spontaneous causes (PVD, retinal vein occlusions) maintain male predominance but less pronounced 26
  • No gender predilection exists for retinal vein occlusion-related vitreous hemorrhage 7

Clinical Management Implications

Surveillance Strategy

Given the higher complication risk in males:

  • Male patients with vitreous hemorrhage from PVD require more intensive monitoring during the first 3 weeks, when RRD risk peaks 5
  • Young male patients warrant particularly vigilant follow-up given their elevated risk profile 53

Spontaneous Clearance

  • Approximately 62% of vitreous hemorrhages from PVD clear spontaneously, but this takes several months (median 60+ days) 5
  • Gender-specific clearance rates are not well-established in the literature, though male patients' higher complication rates may influence surgical decision-making

Important Caveats

The male predominance in vitreous hemorrhage may partially reflect gender differences in healthcare-seeking behavior and occupational trauma exposure rather than purely biological factors. However, the earlier PVD onset in men represents a true biological sex difference 11.

The 3-fold increased RRD risk in males represents the most clinically actionable sex difference, directly impacting monitoring protocols and surgical timing decisions 5.

References

Research

Vitreous hemorrhage in children and adolescents in India.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2013

Research

Clinical profile and management of vitreous hemorrhage in tertiary eye care centre in Nepal.

Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH, 2020

Related Questions

What are the possible differential diagnoses for a 9-year-old girl presenting with retinal vasculitis, vitreous hemorrhage, sensorineural hearing loss, and unilateral facial palsy?
Is the treatment for posterior vitreous detachment the same as the treatment for posterior vitreous hemorrhage?
What are the risk factors for posterior vitreous detachment and the additional risk factors that predict an unfavorable outcome?
What is the appropriate urgency for referring a patient with a suspected vitreous hemorrhage?
Are the conclusions and summary of the study supported by the reported data and statistical analysis?
Do the conclusions of the systematic review on the prevalence and risk factors of shift work disorder among nurses align with the reported data and statistical analyses?
How long should vitamin D (cholecalciferol) 10,000 IU be taken?
What is the appropriate work‑up for a 39‑year‑old woman with bloating, constipation, and vomiting triggered by gluten who continues to have bloating despite a gluten‑free diet?
In a patient with recurrent right‑sided sinus infections over several years and a computed tomography angiography (CTA) showing a mucous retention cyst in the right maxillary sinus with internal calcific density suggesting inspissated secretions and less likely fungal elements, how likely is fungal involvement?
Should a 39-year-old woman with persistent bloating, constipation, and vomiting after gluten ingestion despite a gluten‑free diet be referred to a gastroenterologist?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.